Oxidative/Nitrosative Stress and Antioxidant Strategies in Inflammatory Respiratory Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: 20 November 2024 | Viewed by 74
Special Issue Editor
Interests: rare respiratory diseases; alpha-1 antitrypsin deficiency; primary ciliary dyskinesia; cystic fibrosis; idiopathic pulmonary fibrosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammatory respiratory diseases include, among others, COPD, asthma, interstitial lung diseases, and infectious diseases of the airways. The pathophysiology of these diseases is not fully understood. However, numerous studies have shown that oxidative/nitrosative stress plays an important role in developing these pathologies, which leads to the rationale for using antioxidant strategies to treat these diseases.
Although preclinical studies have shown that antioxidant therapies may be useful in treating these diseases, none of these strategies have demonstrated efficacy in clinical practice. These data suggest that it is necessary to deepen our understanding of the molecular processes related to oxidative/nitrosative stress involved in tissue damage in respiratory inflammatory diseases. This Special Issue aims to collect original research articles, narrative reviews, and systematic reviews with meta-analyses related to oxidative/nitrosative stress and antioxidant strategies in respiratory inflammatory diseases. Both pre-clinical and clinical research studies are welcome. Articles discussing new drugs and/or new drug delivery systems targeting oxidative/nitrosative stress are highly encouraged.
Prof. Dr. Francisco Dasí
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oxidative stress
- antioxidant therapies
- respiratory diseases
